Home › Funds › Caption Management, LLC › CYTK

Caption Management, LLC position in CYTK

CYTOKINETICS INC · Health Care

Caption Management, LLC reported holding 512,400 shares of CYTK (CYTOKINETICS INC) in its Q2 2026 13F filing — a position valued at US$43.7M, representing 0.74% of its reported portfolio and ranking #27 among its reported holdings. Caption Management, LLC has disclosed CYTK holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)512.40K sh
Reported value held$43.65M
Portfolio Weight0.74%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Caption Management, LLC's CYTK position evolved

Caption Management, LLC first disclosed a stake in CYTK in Q3 2023 at 3,300 shares (US$97K). The position peaked in Q2 2026 at 512,400 shares, worth US$43.7M. Across 12 filings, Caption Management, LLC increased the stake 4 time(s), trimmed it 6 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 512,400 shares valued at US$43.7M — an increase of 267,400 shares quarter over quarter.. Notable position changes include a 12638% increase in Q4 2023 (shares fell 16% over the following quarter), a 116% increase in Q2 2025 (shares rose 66% over the following quarter), a 2684% increase in Q1 2026 (shares rose 29% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.30K $97.22K New
Q4 2023 420.36K $35.10M Add
Q1 2024 265.55K $18.62M Reduce
Q2 2024 67.00K $3.63M Reduce
Q3 2024 33.50K $1.77M Reduce
Q4 2024 23.80K $1.12M Reduce
Q1 2025 8.80K $353.67K Reduce
Q2 2025 19.00K $627.76K Add
Q3 2025 8.80K $483.65K Reduce
Q4 2025 8.80K $559.15K Hold
Q1 2026 245.00K $16.15M Add
Q2 2026 512.40K $43.65M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CYTK and 13F data

CYTK (CYTOKINETICS INC) is a Health Care company. 52 other funds we track also report a position in CYTK — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.59B), Avoro Capital Advisors LLC (US$425.9M), RTW INVESTMENTS, LP (US$243.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CYTK

All CYTK fund holders →

FAQ

How long has Caption Management, LLC held CYTK?

Caption Management, LLC has disclosed CYTK holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Caption Management, LLC's current position in CYTK?

As of Q2 2026, Caption Management, LLC holds 512.40K shares of CYTK (CYTOKINETICS INC), valued at $43.65M, representing 0.74% of its reported portfolio and ranking #27.

Has Caption Management, LLC been buying or selling CYTK?

In the latest 13F filing (Q2 2026), Caption Management, LLC increased its position in CYTK. The position peaked in Q2 2026 at 512.40K shares.

Which other funds hold CYTK?

Other major institutional holders of CYTK include T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.